DPP-4 inhibitors and venous thromboembolism: an analysis of the WHO spontaneous reporting database

Lancet Diabetes Endocrinol. 2020 May;8(5):365-367. doi: 10.1016/S2213-8587(20)30112-1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Databases, Factual
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Venous Thromboembolism / chemically induced*
  • Venous Thromboembolism / epidemiology
  • World Health Organization

Substances

  • Dipeptidyl-Peptidase IV Inhibitors